Testing effectiveness (Phase 2)UnknownNCT01830504What this trial is testingPhase II Pilot Open LabelWho this might be right forThyroid Cancers Hospices Civils de Lyon 47
Not applicableLooking for participantsNCT06405217What this trial is testingRecombinant Human Thyroid Stimulating Hormone for Radioiodine 131I TreatmentWho this might be right forDTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications Nanjing First Hospital, Nanjing Medical University 30
Testing effectiveness (Phase 2)UnknownNCT01263951What this trial is testingStudy of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib AloneWho this might be right forDifferentiated Thyroid Cancer Thomas Jefferson University 35
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Large-scale testing (Phase 3)Active Not RecruitingNCT04940052What this trial is testingStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer (DTC) Novartis Pharmaceuticals 153
Not applicableStudy completedNCT02592356What this trial is testingEffect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00118248What this trial is testingTanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid CancerWho this might be right forRecurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093What this trial is testingStudy on the Treatment of Differentiated Thyroid Carcinoma with AnlotinibWho this might be right forDTC - Differentiated Thyroid Cancer Yansong Lin 20
Testing effectiveness (Phase 2)Ended earlyNCT03002623What this trial is testingCUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid CancerWho this might be right forThyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer National Cancer Institute (NCI) 7
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)UnknownNCT04180007What this trial is testingStudy of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid CancersWho this might be right forThyroidMetastasisApatinib Nanjing First Hospital, Nanjing Medical University 10
Not applicableUnknownNCT06062563What this trial is testingStudy of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid CancerWho this might be right forLocally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)UnknownNCT00098852What this trial is testingRosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid CancerWho this might be right forHead and Neck Cancer University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT02973997What this trial is testingLenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)Who this might be right forColumnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more Academic and Community Cancer Research United 57
Post-approval studies (Phase 4)UnknownNCT04683575What this trial is testingClinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid CarcinomaWho this might be right forSelenium DeficiencyThyroid Cancer TNM StagingRecurrence+1 more Qianfoshan Hospital 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03181100What this trial is testingAtezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid CancerWho this might be right forMetastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaStage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8+4 more M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT01413113What this trial is testingIodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By SurgeryWho this might be right forRecurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more University of Washington 6
Testing effectiveness (Phase 2)UnknownNCT03167385What this trial is testingPhase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid CarcinomaWho this might be right forDifferentiated Thyroid Carcinoma Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00061906What this trial is testingCelecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerWho this might be right forHead and Neck Cancer Ohio State University Comprehensive Cancer Center 25
Not applicableActive Not RecruitingNCT04970134What this trial is testingSpanish Study for Molecular Characterization of Thyroid CarcinomaWho this might be right forDifferentiated Thyroid CarcinomaMedullary Thyroid Carcinoma Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150